| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
FAG
|
17.20 | 3.0B | 4.16 | 0.43 | 2.14 | 2.8% | 6.5% | 82 | 64 | 41.90 | +107.7% | 66 | 0.62 |
|
ITAB
|
15.38 | 3.9B | 4.94 | 0.89 | 1.95 | 6.4% | 7.2% | 80 | 67 | 36.66 | +103.8% | 65 | 0.89 |
|
NMAN
|
131.40 | 4.6B | 4.71 | 1.79 | 2.96 | 7.5% | 8.2% | 78 | 66 | 251.57 | +68.6% | 65 | 1.03 |
|
TREL_B
|
425.00 | 82.6B | 5.45 | 2.53 | 3.06 | 11.7% | 8.7% | 78 | 67 | 726.89 | +53.3% | 70 | 0.37 |
|
ALIG
|
125.80 | 13.3B | 6.05 | 1.79 | 3.63 | 7.8% | 8.7% | 75 | 63 | 216.70 | +54.2% | 69 | 0.45 |
|
NIBE_B
|
38.00 | 67.8B | 6.39 | 2.53 | 3.78 | 7.1% | 7.9% | 73 | 62 | 59.75 | +42.9% | 67 | 0.87 |
|
VBG_B
|
313.50 | 7.1B | 4.31 | 1.91 | 2.65 | 9.8% | 9.4% | 73 | 47 | 477.71 | +37.7% | 78 | 0.53 |
|
SYSR
|
82.00 | 17.0B | 5.33 | 2.78 | 3.19 | 12.2% | 9.4% | 72 | 62 | 118.81 | +33.7% | 71 | 0.25 |
|
AQ
|
205.60 | 18.9B | 6.71 | 4.04 | 4.19 | 15.2% | 9.8% | 67 | 61 | 239.23 | +12.3% | 85 | 0.09 |
|
MYCR
|
321.80 | 62.8B | 9.05 | 7.97 | 5.84 | 33.2% | 9.4% | 65 | 73 | 345.90 | +5.6% | 88 | 0.05 |
|
INDT
|
240.80 | 87.7B | 8.18 | 4.91 | 4.71 | 11.4% | 8.8% | 64 | 61 | 311.09 | +21.9% | 67 | 0.61 |
|
MTRS
|
179.25 | 32.7B | 16.13 | 6.22 | 6.05 | 8.5% | 8.7% | 52 | 54 | 180.67 | +0.6% | 63 | 1.49 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.